存活期-话题@MedSci

#存活期#

29篇内容 | 871人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1621188, encodeId=97771621188d7, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。, objectType=article, longId=121145, objectId=f91412114508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f91412114508, replyNumber=0, likeNumber=32, createdTime=2017-11-24, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f91412114508, moduleTitle=Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f91412114508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621187, encodeId=c83e162118e1a, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=Blood：3期FIRST试验：来那度胺联合地塞米松显著提高多发性骨髓瘤患者的无进展存活期。, objectType=article, longId=120760, objectId=bcee120e6041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcee120e6041, replyNumber=0, likeNumber=42, createdTime=2017-11-22, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcee120e6041, moduleTitle=Blood：3期FIRST试验：来那度胺联合地塞米松显著提高多发性骨髓瘤患者的无进展存活期。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcee120e6041)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621186, encodeId=c12b1621186ba, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=Blood：骨髓纤维化患者停用卢索替尼后的存活期情况, objectType=article, longId=104578, objectId=33771045e8ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33771045e8ec, replyNumber=0, likeNumber=45, createdTime=2017-07-06, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33771045e8ec, moduleTitle=Blood：骨髓纤维化患者停用卢索替尼后的存活期情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33771045e8ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621185, encodeId=473f162118565, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=请多吃豆制品：乳腺癌患者可延长存活期, objectType=article, longId=90973, objectId=da41909e3a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da41909e3a6, replyNumber=0, likeNumber=37, createdTime=2017-03-08, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da41909e3a6, moduleTitle=请多吃豆制品：乳腺癌患者可延长存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da41909e3a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621184, encodeId=85c916211848a, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍, objectType=article, longId=56904, objectId=55fe569046c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fe569046c, replyNumber=0, likeNumber=36, createdTime=2015-10-07, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fe569046c, moduleTitle=J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fe569046c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621183, encodeId=90c01621183ae, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=Obstet Gynecol：围存活期剖宫产其子宫破裂的风险更高, objectType=article, longId=50293, objectId=a9575029347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9575029347, replyNumber=0, likeNumber=37, createdTime=2015-05-07, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9575029347, moduleTitle=Obstet Gynecol：围存活期剖宫产其子宫破裂的风险更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9575029347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621182, encodeId=1be91621182bb, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=AJOG：围存活期臀位不同分娩方式结局, objectType=article, longId=48183, objectId=c5594818334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5594818334, replyNumber=0, likeNumber=38, createdTime=2015-03-15, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5594818334, moduleTitle=AJOG：围存活期臀位不同分娩方式结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5594818334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621181, encodeId=f5ac1621181a4, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=J Watch评价：对围存活期分娩的指导建议, objectType=article, longId=46951, objectId=0fbb4695192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fbb4695192, replyNumber=0, likeNumber=33, createdTime=2015-02-12, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fbb4695192, moduleTitle=J Watch评价：对围存活期分娩的指导建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fbb4695192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1621180, encodeId=dbc0162118045, content=<a href='/topic/show?id=5ddb45343ef' target=_blank style='color:#2F92EE;'>#存活期#</a>, objectTitle=Lancet Oncol：药物凡德他尼增加甲状腺癌病人无疾病恶化存活期, objectType=article, longId=9003, objectId=b7ca9003fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7ca9003fb, replyNumber=0, likeNumber=27, createdTime=2012-08-17, rootId=0, userName=hukaixun, userId=498620204611, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7ca9003fb, moduleTitle=Lancet Oncol：药物凡德他尼增加甲状腺癌病人无疾病恶化存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7ca9003fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

存活期

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#存活期#

Lancet oncol：吉非替尼相比长春瑞滨联合顺铂治疗，可显著延长携带EGFR突变的晚期非小细胞肺癌术后患者的无病存活期。

2017-11-24

hukaixun (审核中...)

前往app查看评论内容

#存活期#

Blood：3期FIRST试验：来那度胺联合地塞米松显著提高多发性骨髓瘤患者的无进展存活期。

2017-11-22

hukaixun (审核中...)

前往app查看评论内容

#存活期#

Blood：骨髓纤维化患者停用卢索替尼后的存活期情况

2017-07-06

hukaixun (审核中...)

前往app查看评论内容

#存活期#

请多吃豆制品：乳腺癌患者可延长存活期

2017-03-08

hukaixun (审核中...)

前往app查看评论内容

#存活期#

J Neurooncol：重大突破！基因疗法可使复发性胶质母细胞瘤患者的存活期翻倍

2015-10-07

hukaixun (审核中...)

前往app查看评论内容

#存活期#

Obstet Gynecol：围存活期剖宫产其子宫破裂的风险更高

2015-05-07

hukaixun (审核中...)

前往app查看评论内容

#存活期#

AJOG：围存活期臀位不同分娩方式结局

2015-03-15

hukaixun (审核中...)

前往app查看评论内容

#存活期#

J Watch评价：对围存活期分娩的指导建议

2015-02-12

hukaixun (审核中...)

前往app查看评论内容

#存活期#

Lancet Oncol：药物凡德他尼增加甲状腺癌病人无疾病恶化存活期

2012-08-17

科室
- - 订阅+
  - 更多科室
工具
服务